Sep. 21, 2014, 4:17 AM
- Just months before its recent C-suite shuffle, Clorox (NYSE:CLX) reportedly rebuffed a takeover offer from a rival.
- The spurned suitor valued Clorox at a 20% premium to its trading price.
- Logical suitors include Church & Dwight (NYSE:CHD), Procter & Gamble (NYSE:PG), Jarden (NYSE:JAH) and Unilever (UL, UN)
- In 2011 activist investor Carl Icahn offered $78/share for the company. Many believe the move was designed to tease out a strategic buyer. Shares closed Friday at $90.57.
Aug. 20, 2012, 5:03 PM
Church & Dwight (CHD) is [[acquiring Avid Health]], maker of gummy form vitamins and supplements, for $650M in a combination of debt and cash. The deal is expected to close early in the fourth quarter. Once fully integrated, CHD plans to leverage Avid's distribution network and support functions to generate anticipated annual cost savings of approximately $15M in 2014. Shares +1% AH.| Aug. 20, 2012, 5:03 PM